TYROBP and major depressive disorder: This effect is proposed to be achieved by suppressing the RORγt/IL‐17AR signaling pathway and enhancing the Nrf2/TREM2/DAP12/Arg‐1 pathway, highlighting their cooperative action in mitigating neuroinflammation and depression‐like behaviors (Figure9).